Status:
COMPLETED
Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)
Lead Sponsor:
Organon and Co
Conditions:
Hypercholesterolemia
Coronary Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will evaluate patients who have coronary heart disease to determine if an investigational drug will further lower cholesterol when taken in combination with an approved cholesterol lowering...
Detailed Description
The duration of treatment is 10 weeks.
Eligibility Criteria
Inclusion
- Patients with elevated cholesterol and coronary heart disease
Exclusion
- Patients who do not meet specific cholesterol levels as required by the study
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2004
Estimated Enrollment :
410 Patients enrolled
Trial Details
Trial ID
NCT00092599
Start Date
February 1 2003
End Date
July 1 2004
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.